Anavex Life Sciences Corp (AVXL)

[Gator328]

How do you figure $100/share?

That is nearly $8B for the market cap. I don't know that Rett alone warrants an $8B valuation because there simply aren't enough patients to produce the sort of revenue and cash flow. Even if insurance companies do cover Rett, they're going to negotiate a massive discount on the "retail" cost of Blarcamesine treatments.